Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

1 Green Flag and 1 Red Flag for Amgen

TheMotleyFool

0 0

Amid a gloomier performance from the broader market, the healthcare industry has presented a few bright spots for investors. Amgen (NASDAQ: AMGN), a biotech pioneer that uses living cells to make biologic medicines, has seen its stock rise 10% year-to-date. For context, the S&P 500 has dropped nearly 12% in the same time frame.

Let's look at what's going right for the company and one obstacle it could face.

Image source: Getty Images.

Source Fool.com

Like: 0

AMGN

Share